"
Cannabis Science
™ works with World Authorities on phytocannabinoid science targeting critical illnesses. Adhering to scientific methodologies to develop, produce, and commercialize phytocannabinoid based pharmaceutical products."
Home
Corporate
Products
Research
Communications
Investors
Contact Us
Thursday September 09, 2010
Overview
News Releases
Media Coverage
White Papers
Newsletters
Blog
Forums
Patient Inquiries
Investors
Partnerships
News Release Subscription
Required *
First Name
*
Field not valid (required or bad value)
Last Name
*
Field not valid (required or bad value)
Email
*
Field not valid (required or bad value)
News Releases
Display #
5
10
15
20
25
30
50
100
All
#
Article Title
Date
61
Beacon Equity Issues Trading
Thursday, 30 July 2009
62
Today Dr. Melamede Makes A Statement
Wednesday, 29 July 2009
63
Cannabis Science Receives FDA Industry
Tuesday, 28 July 2009
64
Cannabis Science to Apply to the FDA
Monday, 27 July 2009
65
Today's CNN Pandemic Report on H1N1
Friday, 24 July 2009
66
Today's Wall Street Journal Reports on Cannabis
Thursday, 23 July 2009
67
CBIS President Dr. Robert Melamede Testified
Tuesday, 21 July 2009
68
Dr. Melamede Confirms Pre-IND Procedures
Monday, 20 July 2009
69
The New Cannabis Science President & CEO
Friday, 17 July 2009
70
CBIS Appoints Dr. Robert Melamede, Ph.D.
Thursday, 09 July 2009
71
CBIS Enters into Investor Relations Agreement
Thursday, 02 July 2009
72
A New Audio Interview Featuring
Thursday, 25 June 2009
73
CBIS Development Team Recommends Patent
Thursday, 18 June 2009
74
CBIS Appoints Former Upjohn Senior
Friday, 12 June 2009
75
Can Cannabis-Based Drugs Slow the H1N1
Thursday, 11 June 2009
<<
Start
<
Prev
1
2
3
4
5
6
Next
>
End
>>
Page 5 of 6
Cannabis Science Contact Info | Telephone: 1 888.889.0888 | Fax: 1 866.943.5085 | Email: info@cannabisscience.com
© 2009
Cannabis Science Inc™
(OTCBB: CBIS). All Rights Reserved.
To Top of Page